Jorey Chernett Biography and Net Worth

Major Shareholder of Oncology Institute

Jorey Chernett is the CEO, founder, developer, and marketer of Authentic4D. Jorey has a passion for building and investing in businesses. Jorey previously served as President of D4D Technologies, LLC, a medical device company providing 3D imaging and CNC milling solutions to the $60B dental crown and bridge industry. He led the company inarchitecting and executing its business model, taking D4D through key strategic partnerships, culminating in a sale to strategic investors that included 3M and Henry Schein. Jorey’s past includes experience as a venture capitalist (Illinois Ventures, LLC/Camelot), operator (DigitalWork, Inc.) and investment banker (Donaldson Lufkin & Jenrette). He received his Bachelor of Science degree in Finance with honors from Indiana University.

What is Jorey Chernett's net worth?: The estimated net worth of Jorey Chernett is at least $72.31 million as of August 14th, 2026. Mr. Chernett owns 10,602,988 shares of Oncology Institute stock worth more than $72,312,378 as of September 17th. This net worth approximation does not reflect any other assets that Mr. Chernett may own. Learn More about Jorey Chernett's net worth.
How do I contact Jorey Chernett?: The corporate mailing address for Mr. Chernett and other Oncology Institute executives is 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703. Oncology Institute can also be reached via phone at (562) 735-3226 and via email at [email protected]. Learn More on Jorey Chernett's contact information.
Has Jorey Chernett been buying or selling shares of Oncology Institute?: During the last quarter, Jorey Chernett has bought $261,090.00 in shares of Oncology Institute stock. Most recently, on Friday, August 14th, Jorey Chernett bought 12,000 shares of Oncology Institute stock. The stock was acquired at an average cost of $6.54 per share, with a total value of $78,480.00. Following the completion of the transaction, the insider now directly owns 10,660,858 shares of the company's stock, valued at $69,722,011.32. Learn More on Jorey Chernett's trading history.
Who are Oncology Institute's active insiders?: Oncology Institute's insider roster includes Robert Carter (CFO), Jorey Chernett (Major Shareholder), Brad Hively (Director), Mohit Kaushal (Director), Mark Pacala (Director), Yale Podnos (Director), and Daniel Virnich (CEO). Learn More on Oncology Institute's active insiders.
Are insiders buying or selling shares of Oncology Institute?: In the last twelve months, Oncology Institute insiders bought shares 14 times. They purchased a total of 712,485 shares worth more than $2,447,345.65. In the last twelve months, insiders at the sold shares 7 times. They sold a total of 481,603 shares worth more than $2,657,860.64. The most recent insider tranaction occured on August, 21st when Director Brad Hively sold 298,853 shares worth more than $1,945,533.03. Insiders at Oncology Institute own 4.4% of the company. Learn More about insider trades at Oncology Institute.
Information on this page was last updated on 8/21/2026.

Jorey Chernett Insider Trading History at Oncology Institute

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/14/2026	Buy	12,000	$6.54	$78,480.00	10,660,858
7/21/2026	Buy	18,000	$5.27	$94,860.00	10,648,858
7/10/2026	Buy	15,000	$5.85	$87,750.00	10,630,858
6/23/2026	Buy	18,000	$5.02	$90,360.00	10,615,858
6/4/2026	Buy	12,000	$4.75	$57,000.00	10,579,858
5/20/2026	Buy	33,500	$4.07	$136,345.00	10,567,858
5/19/2026	Buy	30,000	$4.09	$122,700.00	10,529,358
5/19/2026	Buy	5,000	$4.05	$20,250.00	10,534,358
4/9/2026	Buy	20,000	$3.10	$62,000.00	10,499,358
3/24/2026	Buy	125,000	$3.11	$388,750.00	10,401,929
3/20/2026	Buy	25,000	$3.35	$83,750.00	10,276,929
3/17/2026	Buy	75,000	$3.42	$256,500.00	10,251,929
3/16/2026	Buy	60,985	$3.29	$200,640.65	10,176,929
3/13/2026	Buy	263,000	$2.92	$767,960.00	10,115,944

Jorey Chernett Buying and Selling Activity at Oncology Institute

Oncology Institute Company Overview

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.

Today's Range

Now: $6.82

$6.52

$7.00

50 Day Range

MA: N/A

2 Week Range

Now: $6.82

$2.32

$7.05

Volume

1,064,384 shs

Average Volume

1,808,920 shs

Market Capitalization

$674.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41